Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 5 Key Takeaways: Drug and Device Development Secrets in the World of Medical Aesthetics By Premier Research May 27, 2021 Global Compliance Frequently Asked Questions: GxP Quality Guidelines and Regulations By Premier Research May 12, 2021 Clinical ResearchPhase 1 - Phase 4 Product Development Checklist: Considerations for Each Stage of the Drug Development Process By Premier Research April 5, 2021 Patient and Stakeholder Engagement Essential Strategies for Patient-Focused Dermatology Clinical Trials By Premier Research February 2, 2021 Clinical ResearchPhase 1 - Phase 4 Choose the Right FDA Program to Expedite Your Rare Oncology Trial By Premier Research December 2, 2020 Clinical ResearchPhase 1 - Phase 4 Adaptive Design Methods Offer Rapid, Seamless Transition Between Study Phases in Rare Cancer Trials By Premier Research November 17, 2020 Previous 1 2 3 4 … 16 Next × ALSO OF INTERESTUsing the 505(b)(2) Pathway to Streamline...A Fit-for-Purpose Path Forward: Linking RWD to...The Rise of Radiotherapeutics: Brief History...
